* Creative Medical Technology Holdings Inc CELZ.OQ
reported a
quarterly adjusted loss of $1.19 per share for the quarter
ended in December, higher than the same quarter last year, when
the company reported EPS of $-5.30. The lone analyst forecast
for the quarter was for a loss of $1.13 per share.
* Revenue fell 84.2% to $3.00 thousand from a year ago;
analysts
expected zero.
* Creative Medical Technology Holdings Inc's reported EPS
for the
quarter was a loss of $1.19.
* The company reported a quarterly loss of $1.68 million.
* Creative Medical Technology Holdings Inc shares had risen
by 12.6% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Creative
Medical
Technology Holdings Inc is $30.00
This summary was machine generated from LSEG data March 25 at
09:01 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -1.13 -1.19 Missed
Sep. 30 2023 -0.86 -1.02 Missed
Jun. 30 2023 -0.83 -0.78 Beat
Mar. 31 2023 -1.00 -0.70 Beat